{"pmid":32243690,"title":"A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China.","text":["A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China.","In December 2019, an outbreak of COVID-19 occurred in Wuhan, China, and spread to the whole of China and to multiple countries worldwide. Unlike SARS and MERS, where secondary transmission mostly occurred in hospital settings, COVID-19 transmission occurs in large numbers within families. Herein we report three cases of a familial cluster with one family member being a kidney transplant recipient. The initial clinical symptoms of COVID-19 in these three patients were the same, but their progression was different. Based on the severity of clinical symptoms, chest computer tomography findings and SARS-Cov-2 RNA test results, we admitted the husband to the respiratory intensive care unit (RICU) and used a treatment consisting of immunosuppressant reduction/cessation and low dose methylprednisolone-based therapy, and his wife to the respiratory isolation ward. In contrast, the son received in-home isolation and home-based care. All three family members made a full recovery.","Am J Transplant","Chen, Song","Yin, Qin","Shi, Huibo","Du, Dunfeng","Chang, Sheng","Ni, Li","Qiu, Haifang","Chen, Zhishui","Zhang, Jixian","Zhang, Weijie","32243690"],"abstract":["In December 2019, an outbreak of COVID-19 occurred in Wuhan, China, and spread to the whole of China and to multiple countries worldwide. Unlike SARS and MERS, where secondary transmission mostly occurred in hospital settings, COVID-19 transmission occurs in large numbers within families. Herein we report three cases of a familial cluster with one family member being a kidney transplant recipient. The initial clinical symptoms of COVID-19 in these three patients were the same, but their progression was different. Based on the severity of clinical symptoms, chest computer tomography findings and SARS-Cov-2 RNA test results, we admitted the husband to the respiratory intensive care unit (RICU) and used a treatment consisting of immunosuppressant reduction/cessation and low dose methylprednisolone-based therapy, and his wife to the respiratory isolation ward. In contrast, the son received in-home isolation and home-based care. All three family members made a full recovery."],"journal":"Am J Transplant","authors":["Chen, Song","Yin, Qin","Shi, Huibo","Du, Dunfeng","Chang, Sheng","Ni, Li","Qiu, Haifang","Chen, Zhishui","Zhang, Jixian","Zhang, Weijie"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243690","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15903","keywords":["COVID-19","kidney","novel coronavirus","pneumonia","transplantation","treatment"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1663079112835596289,"score":7.6048946,"similar":[{"pmid":32181990,"title":"Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.","text":["Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.","The current outbreak of Coronavirus Disease 2019 (COVID-19) has raised great concern worldwide, but its impact on transplant recipients is unknown. We report here the clinical features and therapeutic course of the first reported renal transplant recipient with confirmed COVID-19 pneumonia. This is a 52-year-old man who received kidney transplantation 12 years ago. His overall clinical characteristics (symptoms, laboratory examinations, and chest CT) were similar to those of non-transplanted COVID-19 patients. Following a treatment regimen consisting of reduced immunosuppressant use and low dose methylprednisolone-based therapy, the COVID-19 pneumonia in this long-term immunosuppressive patient was successfully recovered. This effectively treated case has reference value for the future treatment of other transplant patients with COVID-19 pneumonia.","Am J Transplant","Zhu, Lan","Xu, Xizhen","Ma, Ke","Yang, Junling","Guan, Hanxiong","Chen, Song","Chen, Zhishui","Chen, Gang","32181990"],"abstract":["The current outbreak of Coronavirus Disease 2019 (COVID-19) has raised great concern worldwide, but its impact on transplant recipients is unknown. We report here the clinical features and therapeutic course of the first reported renal transplant recipient with confirmed COVID-19 pneumonia. This is a 52-year-old man who received kidney transplantation 12 years ago. His overall clinical characteristics (symptoms, laboratory examinations, and chest CT) were similar to those of non-transplanted COVID-19 patients. Following a treatment regimen consisting of reduced immunosuppressant use and low dose methylprednisolone-based therapy, the COVID-19 pneumonia in this long-term immunosuppressive patient was successfully recovered. This effectively treated case has reference value for the future treatment of other transplant patients with COVID-19 pneumonia."],"journal":"Am J Transplant","authors":["Zhu, Lan","Xu, Xizhen","Ma, Ke","Yang, Junling","Guan, Hanxiong","Chen, Song","Chen, Zhishui","Chen, Gang"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32181990","week":"202012|Mar 16 - Mar 22","doi":"10.1111/ajt.15869","keywords":["COVID-19","Coronavirus","Pneumonia","immunosuppression","renal transplantation"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1662334543538946048,"score":344.70273},{"pmid":32243673,"title":"Successful Treatment of Severe COVID-19 Pneumonia in a Liver Transplant Recipient.","text":["Successful Treatment of Severe COVID-19 Pneumonia in a Liver Transplant Recipient.","Coronavirus disease 2019 (COVID-19) pandemic spreads rapidly and may be an increasing challenge for transplant community. Clinical data on COVID-19 infection in transplant population is very limited. Herein we presented the clinical course and outcome of a 50-year-old male post liver transplantation who contracted COVID-19, with subsequent infection of his wife. The process of illness was representative. A therapeutic regime with temporary immunosuppression withdrawal and systemic low-dose corticosteroid as principle was involved in the management of the patient which made him recover from severe COVID-19 pneumonia.","Am J Transplant","Bin, Liu","Yangzhong, Wang","Yuanyuan, Zhao","Huibo, Shi","Fanjun, Zeng","Zhishui, Chen","32243673"],"abstract":["Coronavirus disease 2019 (COVID-19) pandemic spreads rapidly and may be an increasing challenge for transplant community. Clinical data on COVID-19 infection in transplant population is very limited. Herein we presented the clinical course and outcome of a 50-year-old male post liver transplantation who contracted COVID-19, with subsequent infection of his wife. The process of illness was representative. A therapeutic regime with temporary immunosuppression withdrawal and systemic low-dose corticosteroid as principle was involved in the management of the patient which made him recover from severe COVID-19 pneumonia."],"journal":"Am J Transplant","authors":["Bin, Liu","Yangzhong, Wang","Yuanyuan, Zhao","Huibo, Shi","Fanjun, Zeng","Zhishui, Chen"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243673","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15901","keywords":["coronavirus disease 2019","liver","transplantation"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663079112855519232,"score":316.31183},{"pmid":32133831,"title":"[Epidemiological analysis on a family cluster of COVID-19].","text":["[Epidemiological analysis on a family cluster of COVID-19].","Objective: To understand the possible transmission route of a family cluster of COVID-19 in Zhengzhou and the potential infectivity of COVID-19 in incubation period, and provide scientific evidence for the timely control of infectious source and curb the spread of the epidemic. Methods: Epidemiological investigation was conducted for a family cluster of COVID-19 (8 cases) with descriptive epidemiological method, and respiratory tract samples of the cases were collected for the nucleic acid detection of 2019-nCoV by RT-PCR. Results: Two primary cases, which occurred on 31 January and 1 February, 2020, respectively, had a common exposure history in Wuhan. The other six family members had onsets on 30 January, 31 January, 1 February (three cases) and 3 February, 2020. Conclusions: In this family cluster of COVID-19, six family members were infected through common family exposure to the 2 primary cases. Five secondary cases had onsets earlier than or on the same day as the primary cases, indicating that COVID-19 is contagious in incubation period, and the home isolation in the early phase of the epidemic might lead to the risk of family cluster of COVID-19.","Zhonghua Liu Xing Bing Xue Za Zhi","Qiu, Y Y","Wang, S Q","Wang, X L","Lu, W X","Qiao, D","Li, J B","Gu, Y Y","Zeng, Y","Chen, Y","Bai, W Z","Xu, B L","Han, T W","32133831"],"abstract":["Objective: To understand the possible transmission route of a family cluster of COVID-19 in Zhengzhou and the potential infectivity of COVID-19 in incubation period, and provide scientific evidence for the timely control of infectious source and curb the spread of the epidemic. Methods: Epidemiological investigation was conducted for a family cluster of COVID-19 (8 cases) with descriptive epidemiological method, and respiratory tract samples of the cases were collected for the nucleic acid detection of 2019-nCoV by RT-PCR. Results: Two primary cases, which occurred on 31 January and 1 February, 2020, respectively, had a common exposure history in Wuhan. The other six family members had onsets on 30 January, 31 January, 1 February (three cases) and 3 February, 2020. Conclusions: In this family cluster of COVID-19, six family members were infected through common family exposure to the 2 primary cases. Five secondary cases had onsets earlier than or on the same day as the primary cases, indicating that COVID-19 is contagious in incubation period, and the home isolation in the early phase of the epidemic might lead to the risk of family cluster of COVID-19."],"journal":"Zhonghua Liu Xing Bing Xue Za Zhi","authors":["Qiu, Y Y","Wang, S Q","Wang, X L","Lu, W X","Qiao, D","Li, J B","Gu, Y Y","Zeng, Y","Chen, Y","Bai, W Z","Xu, B L","Han, T W"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32133831","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.cn112338-20200221-00147","keywords":["COVID-19","Epidemiological analysis","Family cluster"],"source":"PubMed","locations":["Zhengzhou","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1662334543989833728,"score":303.23877},{"pmid":32171192,"title":"[Epidemiological characteristics of 2019 novel coronavirus family clustering in Zhejiang Province].","text":["[Epidemiological characteristics of 2019 novel coronavirus family clustering in Zhejiang Province].","Objective: Family clusters of Novel coronavirus pneumonia in Zhejiang province were analyzed to provide epidemiological basis for disease control. Methods: The data of family clusters occurred from January 20 to February 10 in Zhejiang Province were collected. Descriptive analysis was used to analyze the clinical symptoms and the serial interval between the subsequent cases and the index cases. Chi-square test was used to analyze the age distribution, gender distribution and the relationship between the subsequent cases and the index cases. Results: 391 cases including 148 family index cases, 189 subsequent cases and 54 asymptomatic infected cases. The clinical symptoms between family index cases and subsequent cases are similar, fever is the most common symptoms in the two groups 114 (77.03%) and 92 (48.68%) respectively, the cases with diarrhea symptoms accounted for the least proportion, which were 7 (4.73%) and 5 (2.65%). The serial interval between the family index cases and the subsequent cases [M (P(25), P(75))] was 3.00 (1.00, 6.00) days. Family secondary attack rate for subsequent cases and asymptomatic infected cases are 31.61% and 43.20% respectively, the family secondary attack rate of the spouses of the family index cases is 63.87%, and are higher than that of their children (30.53%), parents (28.37%) and other family members (20.93%), the difference was statistically significant. Conclusion: 2019 novel coronavirus has shorter serial interval and higher family secondary attack rate, the secondary attack rate of spouses is higher than other family members.","Zhonghua Yu Fang Yi Xue Za Zhi","Sun, W W","Ling, F","Pan, J R","Cai, J","Miao, Z P","Liu, S L","Cheng, W","Chen, E F","32171192"],"abstract":["Objective: Family clusters of Novel coronavirus pneumonia in Zhejiang province were analyzed to provide epidemiological basis for disease control. Methods: The data of family clusters occurred from January 20 to February 10 in Zhejiang Province were collected. Descriptive analysis was used to analyze the clinical symptoms and the serial interval between the subsequent cases and the index cases. Chi-square test was used to analyze the age distribution, gender distribution and the relationship between the subsequent cases and the index cases. Results: 391 cases including 148 family index cases, 189 subsequent cases and 54 asymptomatic infected cases. The clinical symptoms between family index cases and subsequent cases are similar, fever is the most common symptoms in the two groups 114 (77.03%) and 92 (48.68%) respectively, the cases with diarrhea symptoms accounted for the least proportion, which were 7 (4.73%) and 5 (2.65%). The serial interval between the family index cases and the subsequent cases [M (P(25), P(75))] was 3.00 (1.00, 6.00) days. Family secondary attack rate for subsequent cases and asymptomatic infected cases are 31.61% and 43.20% respectively, the family secondary attack rate of the spouses of the family index cases is 63.87%, and are higher than that of their children (30.53%), parents (28.37%) and other family members (20.93%), the difference was statistically significant. Conclusion: 2019 novel coronavirus has shorter serial interval and higher family secondary attack rate, the secondary attack rate of spouses is higher than other family members."],"journal":"Zhonghua Yu Fang Yi Xue Za Zhi","authors":["Sun, W W","Ling, F","Pan, J R","Cai, J","Miao, Z P","Liu, S L","Cheng, W","Chen, E F"],"date":"2020-03-16T11:00:00Z","year":2020,"_id":"32171192","week":"202012|Mar 16 - Mar 22","doi":"10.3760/cma.j.cn112150-20200227-00199","keywords":["Family aggregation","Novel coronavirus pneumonia","Secondary attack rate","Serial interval"],"source":"PubMed","locations":["Zhejiang"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Diagnosis"],"weight":1,"_version_":1663095625970876417,"score":291.66653},{"pmid":32243697,"title":"COVID-19 in post-transplantation patients- report of two cases.","text":["COVID-19 in post-transplantation patients- report of two cases.","Coronavirus Disease 2019 (COVID-19) has become a pandemic since March 2020. We describe here, two cases of COVID-19 infection in a post-transplant setting. First one is a 59-year old renal transplant recipient; the second is a 51-year old allogeneic bone marrow transplant recipient. Both patients were on immunosuppressant therapy and had stable graft function before COVID-19 infection. After the diagnosis of COVID-19, immunosuppressive agents were discontinued and methylprednisolone with prophylactic antibiotics were initiated, however, the lung injury progressed. The T cells were extremely low in both patients after infection. Both patients died despite the maximal mechanical ventilatory support. Therefore, the prognosis of COVID-19 pneumonia following transplantation is not optimistic and remains guarded. Lower T cell count may be a surrogate for poor outcome.","Am J Transplant","Huang, Jiaofeng","Lin, Heng","Wu, Yinlian","Fang, Yingying","Kumar, Rahul","Chen, Gongping","Lin, Su","32243697"],"abstract":["Coronavirus Disease 2019 (COVID-19) has become a pandemic since March 2020. We describe here, two cases of COVID-19 infection in a post-transplant setting. First one is a 59-year old renal transplant recipient; the second is a 51-year old allogeneic bone marrow transplant recipient. Both patients were on immunosuppressant therapy and had stable graft function before COVID-19 infection. After the diagnosis of COVID-19, immunosuppressive agents were discontinued and methylprednisolone with prophylactic antibiotics were initiated, however, the lung injury progressed. The T cells were extremely low in both patients after infection. Both patients died despite the maximal mechanical ventilatory support. Therefore, the prognosis of COVID-19 pneumonia following transplantation is not optimistic and remains guarded. Lower T cell count may be a surrogate for poor outcome."],"journal":"Am J Transplant","authors":["Huang, Jiaofeng","Lin, Heng","Wu, Yinlian","Fang, Yingying","Kumar, Rahul","Chen, Gongping","Lin, Su"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243697","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15896","keywords":["COVID-19","Coronavirus","transplantation"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663079112883830784,"score":278.29108}]}